Table 3. Multivariate Logistic Regression Analysis of Preventive Care by Patient Groups (n = 579)

	Annual Mammography		Pap in the Past 2 Years		Colonoscopy (n = 371)
	AOR (95% CI)	P Value	AOR (95% CI)	P Value	AOR (95% CI)	P Value
Age >50 years	1.34 (0.86–2.11)	.200	0.29 (0.18–0.47)	<.0001	1.03 (0.99–1.07)	.095
Any comorbidity (yes)^*	1.49 (0.89–2.47)	.127	0.71 (0.45–1.12)	.148	1.30 (0.82–2.05)	.269
Married/partnered (yes)	1.42 (0.89–2.27)	.140	1.35 (0.85–2.15)	.208	0.96 (0.61–1.53)	.870
High school graduate (yes)	0.77 (0.44–1.36)	.369	0.87 (0.49–1.55)	.639	1.21 (0.69–2.11)	.503
Ethnicity (reference: white)
African American	0.99 (0.36–2.74)	.985	1.71 (0.60–4.89)	.315	1.38 (0.42–4.53)	.593
Less-acculturated Latina	1.73 (0.94–3.18)	.077	2.76 (1.50–5.08)	.001	0.72 (0.40–1.30)	.273
More-acculturated Latina	0.76 (0.32–1.81)	.536	3.44 (1.10–10.75)	.034	1.48 (0.55–3.97)	.438
Other	1.43 (0.62–3.31)	.409	1.56 (0.71–3.46)	.269	0.95 (0.42–2.18)	.903
Stage III	0.63 (0.36–1.10)	.106	0.88 (0.49–1.58)	.658	1.09 (0.58–2.02)	.794
Hormone therapy (yes)	1.65 (1.04–2.62)	.033	1.98 (1.23–3.18)	.0047	1.30 (0.80–2.13	.296
Doctor visit group (reference: surgeon/cancer specialist only)
PCP only	2.67 (0.84–5.74)	.109	2.90 (1.05–8.04)	.040	2.99 (1.5–8.51)	.041
Both PCP and cancer specialist	2.20 (1.51–4.72)	.0008	2.24 (1.22–4.10)	.009	2.17 (1.10–4.30)	.026
Financial adequacy (yes)	0.89 (0.55–1.42)	.612	1.28 (0.79–2.09)	.321	0.78 (0.48–1.25)	.296
Competing life needs (yes)	0.81 (0.48–1.38)	.443	0.91 (0.52–1.58)	.741	1.61 (0.92–2.82)	.099
Access to medical care (reference: very difficult/somewhat difficult )	0.66 (0.41–1.09)	.104	0.95 (0.58–1.55)	.826	1.73 (1.06–2.83)	.029

↵* One or more major comorbidity vs. none.
AOR, adjusted odds ratio; CI, confidence interval; Pap, Papanicolaou test; PCP, primary care provider.